L-Cycloserine
- Generic Name
- L-Cycloserine
- Brand Names
- Seromycin
- Drug Type
- Small Molecule
- Chemical Formula
- C3H6N2O2
- CAS Number
- 339-72-0
- Unique Ingredient Identifier
- AK7DRB7FMO
- Background
Antibiotic substance produced by Streptomyces garyphalus.
- Indication
本品与其他抗结核药联合，用于经一线药物（如吡嗪酰胺、链霉素、异烟肼、利福平和乙胺丁醇）治疗失败的患者。本品还可用于治疗非结核分枝杆菌感染如鸟复合分枝杆菌病的治疗。
- Associated Conditions
- Pulmonary Tuberculosis (TB), Tuberculosis, Extrapulmonary, Grade 1, grade 2, grade 3, grade 4 Urinary Tract Infection
- Associated Therapies
- -
Cognitive Remediation With D-Cycloserine
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2018-09-26
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT01399866
- Locations
- 🇺🇸
Massachusetts General Hospital - Center For Addiction Medicine, Boston, Massachusetts, United States
The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
- First Posted Date
- 2011-05-27
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 51
- Registration Number
- NCT01361633
- Locations
- 🇺🇸
Anxiety Disorders Center, Institute of Living/Hartford Hospital, Hartford, Connecticut, United States
The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) Patients
- First Posted Date
- 2011-04-28
- Last Posted Date
- 2011-04-28
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 100
- Registration Number
- NCT01343862
- Locations
- 🇮🇱
Rambam Medical Center, Haifa, Israel
🇮🇱Sheba Medical Center, Ramat Gan, Israel
🇮🇱Hadassah Medical Center, Jerusalem, Israel
D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD
- Conditions
- Interventions
- First Posted Date
- 2010-07-30
- Last Posted Date
- 2014-08-19
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 16
- Registration Number
- NCT01172873
- Locations
- 🇺🇸
New York State Psychiatric Institute/Columbia University, New York City, New York, United States
Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth
- Conditions
- Interventions
- First Posted Date
- 2010-07-07
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- Tulane University School of Medicine
- Target Recruit Count
- 33
- Registration Number
- NCT01157416
- Locations
- 🇺🇸
Tulane University Health Sciences Center, 1440 Canal St., New Orleans, Louisiana, United States
D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents
- Conditions
- Interventions
- First Posted Date
- 2010-07-07
- Last Posted Date
- 2017-06-06
- Lead Sponsor
- Tulane University School of Medicine
- Target Recruit Count
- 24
- Registration Number
- NCT01157429
- Locations
- 🇺🇸
Tulane University Health Sciences Center, 1440 Canal St., New Orleans, Louisiana, United States
D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
- Conditions
- Interventions
- First Posted Date
- 2010-04-13
- Last Posted Date
- 2013-02-21
- Lead Sponsor
- Southern Methodist University
- Target Recruit Count
- 40
- Registration Number
- NCT01102803
- Locations
- 🇺🇸
Southern Methodist University, Dallas, Texas, United States
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
- Conditions
- Interventions
- First Posted Date
- 2010-03-15
- Last Posted Date
- 2016-04-14
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 68
- Registration Number
- NCT01086475
- Locations
- 🇺🇸
Riley Hospital for Children, Indianapolis, Indiana, United States
🇺🇸Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Investigation of Cycloserine as a Smoking Cessation Treatment
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 34
- Registration Number
- NCT01062932
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights
- Conditions
- Interventions
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- CAMC Health System
- Target Recruit Count
- 80
- Registration Number
- NCT01037101
- Locations
- 🇺🇸
West Virginia University School of Medicine Charleston Division, Charleston, West Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.